Intuit 1Q Profit Surges On Strong Revenue Growth
By Ben Glickman
Intuit's fiscal first-quarter profit jumped after the company logged sharp growth in its small business and self-employed group.
The Mountain View, Calif.-based financial technology software provider logged a profit of $241 million, or 85 cents a share, in the quarter ended Oct. 31, compared with $40 million, or 14 cents a share, a year earlier. Analysts polled by FactSet expected per-share earnings of 20 cents.
Stripping out certain one-time items, adjusted per-share earnings came to $2.47, ahead of the $1.98 forecast by analysts, according to FactSet.
Revenue rose 15% to $2.98 billion, beating the $2.88 billion expected by analysts polled by FactSet.
The company's results were boosted by higher revenue in its small business and self-employed group. The group saw more customers and higher effective prices, Intuit said.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
November 28, 2023 16:28 ET (21:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track